Carbogen Amcis acquires French company, Creapharm Parenterals

摘要

Switzerland-based Carbogen Amcis AG, a leading pharmaceutical process development and active pharmaceutical ingredient (API) manufacturing company, has announced the acquisition of Creapharm Parenterals, a subsidiary of France-based Creapharm Group.Creapharm Parenterals (formerly MP5), is a contract development and manufacturing organization (CDMO) specializing in liquid, semi-solid and injectable aseptic dosage forms. As part of this acquisition, Creapharm Parenterals has changed its name to Carbogen Amcis SAS.